Molecular Modeling Applied to the Discovery of New Lead Compounds for P2 Receptors Based on Natural Sources
Open Access
- 29 September 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 01221
Abstract
P2 receptors are a family of transmembrane receptors activated by nucleotides and nucleosides. Two classes have been described in mammals, P2X and P2Y, which are implicated in various diseases. Currently, only P2Y12 has medicines approved for clinical use as antiplatelet agents and natural products have emerged as a source of new drugs with action on P2 receptors due to the diversity of chemical structures. In drug discovery, in silico virtual screening (VS) techniques have become popular because they have numerous advantages, which include the evaluation of thousands of molecules against a target, usually proteins, faster and cheaper than classical high throughput screening (HTS). The number of studies using VS techniques has been growing in recent years and has led to the discovery of new molecules of natural origin with action on different P2X and P2Y receptors. Using different algorithms it is possible to obtain information on absorption, distribution, metabolism, toxicity, as well as predictions on biological activity and the lead-likeness of the selected hits. Selected biomolecules may then be tested by molecular dynamics and, if necessary, rationally designed or modified to improve their interaction for the target. The algorithms of these in silico tools are being improved to permit the precision development of new drugs and, in the future, this process will take the front of drug development against some central nervous system (CNS) disorders. Therefore, this review discusses the methodologies of in silico tools concerning P2 receptors, as well as future perspectives and discoveries, such as the employment of artificial intelligence in drug discovery.Keywords
This publication has 125 references indexed in Scilit:
- P2 receptors and immunityMicrobes and Infection, 2012
- Molecular mechanism of ATP binding and ion channel activation in P2X receptorsNature, 2012
- Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptorJournal of Computer-Aided Molecular Design, 2011
- Pharmacochemistry of the platelet purinergic receptorsPurinergic Signalling, 2011
- P2Y nucleotide receptors: promise of therapeutic applicationsDrug Discovery Today, 2010
- Crystal structure of the ATP-gated P2X4 ion channel in the closed stateNature, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Natural products and drug discoveryEMBO Reports, 2009
- Plant-derived compounds in clinical trialsDrug Discovery Today, 2008
- Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain statesBritish Journal of Pharmacology, 2007